U.S. Basic Materials Stock News

Boston Scientific (BSX) is under scrutiny after a series of voluntary Class II recalls of its CRE and CRE Pro Wireguided endoscopy devices, prompted by potential sterile packaging breaches affecting tens of thousands of units globally. See our latest analysis for Boston Scientific. The recalls arrive after a period of sharp share price weakness, with Boston Scientific’s stock down 30.53% on a 3 month share price return basis and 52.89% year to date. The 1 year total shareholder return has...

Teva Pharmaceutical Industries recently reported encouraging Phase 1b data for its investigational anti‑IL‑15 antibody TEV‑408 in non‑segmental vitiligo, showing improved skin repigmentation with no new safety issues and confirming plans to move into a Phase 2b trial supported by up to US$500.00 million in external R&D funding. The quarterly subcutaneous dosing schedule and dual development in vitiligo and celiac disease position TEV‑408 as a potentially differentiated asset within Teva’s...

Earlier this week, JetBlue and financial technology firm ClarityPay launched an embedded pay-later program that lets eligible customers finance bookings over 6-week to 48-month terms, including an introductory 0% APR for up to 12 months through mid-August 2026, while still earning TrueBlue points on eligible purchases. By integrating AI-driven, white-label financing directly into its booking and loyalty ecosystem, JetBlue is turning payment flexibility into a customer planning and conversion...

Synopsys stock has pulled back over the past year, yet there is a clear split on value, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to meaningful upside while market multiples suggest the shares are on the expensive side. Over 5 years, Synopsys has delivered a gain of 48.1%, which puts the recent weakness into a longer track record of positive returns. The shift away from legacy manufacturing analytics toward AI driven chip design tools may support future cash flow,...

Why Boey’s European approval matters for AbbVie investors AbbVie (ABBV) is back in focus after Allergan Aesthetics secured European Commission approval for Boey, a rapid onset, short duration facial injectable that extends the company’s aesthetics reach across 30 European countries. This new product sits alongside growing interest in AbbVie’s neuroscience and immunology portfolios. It gives investors fresh information to consider when thinking about how different segments might support the...

After a 134.0% total return over the past 5 years, HBT Financial now trades at US$33.39. The central question is whether that performance is fully reflected in the price when set against its intrinsic value estimate and broader valuation checks. A 134.0% 5 year return indicates that long term shareholders in HBT Financial have already seen substantial value created, so any new position needs a clear view on remaining upside. The Excess Returns model suggests the intrinsic value sits...

Arcos Dorados Holdings Inc. has moved to redeem all of its outstanding 6.125% sustainability-linked senior notes due 2029, at 103.063% of principal plus accrued interest, with the redemption completed on July 16, 2026. This decision reshapes the company’s capital structure by retiring a relatively high-coupon instrument, potentially improving interest expense efficiency and highlighting management’s focus on balance sheet quality and financial flexibility. Next, we’ll examine how retiring...

Organized retail crime and rising tap to pay fraud are putting a fresh spotlight on the payment technology and fintech space, as retailers face security gaps, rising chargebacks, and the potential impact of new legislation like the Combating Organized Retail Crime Act. For investors, the question is which stocks could see stronger demand for their tools and services as the cost of fraud climbs toward an estimated $1b a year, and which might face higher risk. This article looks at 3 stocks...

RingCentral (RNG) is back in focus after a mixed quarterly update, with revenue of $644.2 million meeting expectations while full-year EPS guidance topped forecasts, but billings and peer-relative performance fell short. See our latest analysis for RingCentral. RingCentral’s latest results landed after a strong run, with a 1-month share price return of 9.78% and year to date share price return of 51.40%. However, the stock is still working through mixed sentiment following the post earnings...

Earlier this week, Shift4 Payments launched Shift4 One, an all‑in‑one handheld solution that combines payments, dynamic currency conversion, and tax‑free shopping, initially rolled out across the UK, Ireland, Spain and Germany with plans to reach 15 European countries by year‑end. The product is the first jointly developed offering since Shift4 acquired Global Blue, pairing Shift4’s payment capabilities with Global Blue’s tax‑refund expertise to automate eligibility detection and streamline...

IonQ (IONQ) has grabbed attention after reporting strong revenue growth, a sharp jump in its customer backlog to about US$470 million, and lifting full year guidance to a range of US$260 million to US$270 million. See our latest analysis for IonQ. Despite the upbeat revenue and backlog news, IonQ's recent share price return has been weak, with the stock down 6.42% over one day, 37.39% over 30 days, and 24.95% year to date, while the 5 year total shareholder return of 252.41% still reflects...

Capital Southwest (CSWC) shares were in focus after the company issued preliminary earnings guidance for the quarter ended June 30, 2026, outlining expected pre tax and net investment income per share. See our latest analysis for Capital Southwest. At a share price of $24.21, Capital Southwest has posted a 1-month share price return of 4.22% and an 8.61% share price return year to date. Its 1-year total shareholder return of 16.67% and 5-year total shareholder return of 70.72% point to...

Maze Therapeutics stock has delivered a strong 59.2% return over the past year, yet its low value score and an overvalued read on market multiples suggest investors are paying up without a clear margin of safety. Over the last 12 months, Maze Therapeutics has returned 59.2%, which puts the spotlight on whether recent gains already reflect much of the good news investors expect. Future progress in turning its pipeline into consistent, scalable cash flows can support the current share price,...

Lumentum Holdings was recently upgraded by Zacks to a Rank #2 (Buy) after analysts raised earnings estimates amid rising demand for its optical components in AI-focused data centers, supported by fresh capital from an NVIDIA-led investment. This combination of stronger earnings expectations and AI data center exposure highlights how shifts in infrastructure spending can quickly reshape analyst views on Lumentum’s fundamentals. We’ll now examine how this Zacks upgrade, driven by higher...

Kratos Defense & Security Solutions (KTOS) recently secured about US$400 million in new Department of Defense funding for hypersonic and other national security programs, alongside major manufacturing expansions in Pennsylvania and Oklahoma aimed at increasing defense production capacity. See our latest analysis for Kratos Defense & Security Solutions. Despite the series of new contracts and facility expansions, Kratos Defense & Security Solutions has seen its share price fall 16.65% over the...

Domino's Pizza (DPZ) is drawing fresh attention after a series of leadership changes, including the planned promotion of COO Joe Jordan to CEO and new board appointments from Best Buy, Dollar Tree and HP. See our latest analysis for Domino's Pizza. The leadership announcements appear to have sparked renewed interest in Domino's Pizza, with the share price up 6.05% on the day and 9.57% over the past week. However, the year to date share price return of 22.48% and 1 year total shareholder...

USA Rare Earth, Inc. recently announced that its Wheat Ridge, Colorado hydrometallurgical facility has produced commercial-grade dysprosium oxide and neodymium-praseodymium oxide samples from recycled rare earth magnet scrap, known as swarf. By turning recycled magnet scrap into saleable oxides that can be processed at its Less Common Metals subsidiary in the U.K., the company is taking a concrete step toward a more circular and regionally diversified rare earth magnet supply chain outside...

Federated Hermes (FHI) has released updated month end portfolio composition and performance data for its Federated Hermes Premier Municipal Income Fund as of June 30, 2026. This provides fresh detail for investors tracking its municipal exposure. See our latest analysis for Federated Hermes. Recent monthly fund disclosures arrive as Federated Hermes trades at $59.62, with a 90 day share price return of 5.17% and year to date share price return of 13.84%, alongside a 5 year total shareholder...

Fresh scrutiny of Automatic Data Processing (ADP) focuses on whether AI driven competitors could chip away at its payroll and HR margins, potentially affecting pricing power and returns for investors who are watching the stock’s current valuation. See our latest analysis for Automatic Data Processing. Automatic Data Processing’s recent 1 month share price return of 15.57% and 90 day share price return of 27.98% suggest momentum has picked up, even though the 1 year total shareholder return...

Earlier this year, Veeva Systems reported first-quarter fiscal 2027 results that surpassed expectations, with Subscription services and ongoing CRM migrations underpinning performance and recent AI-focused acquisitions broadening its product capabilities. An interesting aspect of this update is how Veeva’s AI strategy, reinforced by acquisitions, aims to deepen its role in life sciences workflows despite CRM market saturation. Next, we’ll examine how Veeva’s stronger-than-expected quarter...

Mosaic recently announced that it released its second quarter 2026 earnings on August 4 and held an investor call on August 5 to discuss results, against a backdrop of weaker earnings and ongoing operational challenges in key fertilizer markets. At the same time, analysts and investors are highlighting Mosaic’s apparent undervaluation and the US Department of Agriculture’s US$500 million fertilizer production funding as potentially supportive for the company’s long-term demand outlook...

In recent sessions, Sea Limited has faced softer analyst sentiment, with earnings estimate cuts contributing to a weaker near-term outlook despite earlier expectations for higher earnings and revenue this year. At the same time, routine insider share sales under Rule 10b5-1 plans and an ongoing US$1.00 billion buyback highlight management’s continued, but nuanced, alignment with shareholder interests. We’ll now examine how these negative earnings estimate revisions, alongside the broader...

HEICO stock has returned 153.6% over the past five years, yet the current valuation checks paint a picture of shares trading at a premium, with both the intrinsic value estimate from a Discounted Cash Flow (DCF) approach and traditional multiples pointing to limited value on offer at today’s levels. Over five years, HEICO has delivered a 153.6% return, which puts extra focus on whether the current price leaves enough margin of safety for new capital. The recent $1.2b senior notes offering...

Oshkosh stock has delivered a 67.8% return over the past three years, yet the latest intrinsic value work using a Discounted Cash Flow (DCF) approach still points to the shares trading at a discount of about 42.7% to that estimate, with the broader checks also leaning toward undervaluation. Over the past three years, Oshkosh has returned 67.8%. This puts recent gains into focus when weighing how much upside, if any, may be left in the current share price. Future valuation can be supported if...